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a b s t r a c t
Pandemic H1N1 inﬂuenza A (H1N1pdm) elicits stronger pulmonary inﬂammation than previously
circulating seasonal H1N1 inﬂuenza A (sH1N1), yet mechanisms of inﬂammatory activation in
respiratory epithelial cells during H1N1pdm infection are unclear. We investigated host responses to
H1N1pdm/sH1N1 infection and virus entry mechanisms in primary human bronchial epithelial cells
in vitro. H1N1pdm infection rapidly initiated a robust inﬂammatory gene signature (3 h post-infection)
not elicited by sH1N1 infection. Protein secretion inhibition had no effect on gene induction. Infection
with membrane fusion deﬁcient H1N1pdm failed to induce robust inﬂammatory gene expression which
was rescued with restoration of fusion ability, suggesting H1N1pdm directly triggered the inﬂammatory
signature downstream of membrane fusion. Investigation of intra-virion components revealed H1N1pdm
viral RNA (vRNA) triggered a stronger inﬂammatory phenotype than sH1N1 vRNA. Thus, our study is ﬁrst
to report H1N1pdm induces greater inﬂammatory gene expression than sH1N1 in vitro due to direct
virus–epithelial cell interaction.
& 2013 The Authors. Published by Elsevier Inc.
Introduction
In 2009, novel variant pandemic H1N1 inﬂuenza A (H1N1pdm)
emerged from Mexico and the southwestern United States (Perez-
Padilla et al., 2009). The rapid spread of H1N1pdm during the ﬁrst
(Summer 2009) and second (Fall/Winter 2009/2010) pandemic
waves (Helferty et al., 2010) led to replacement of the previous
antigenically-related seasonal H1N1 inﬂuenza A (sH1N1) strains
with the seasonal circulation of the H1N1pdm virus worldwide
(Pica et al., 2012; Huang et al., 2013). While H1N1pdm infection
often does not require hospitalization (Nicoll and Coulombier,
2009; Bautista et al., 2010; Gilsdorf and Poggensee, 2009), the
clinical pathology as well as virus localization within the respira-
tory tract differs signiﬁcantly from sH1N1 infection (Childs et al.,
2009; Shieh et al., 2010; Mauad et al., 2010). Speciﬁcally, the
H1N1pdm virus has been shown to bind both α2,6-linked sialic
acid receptors and α2,3-linked sialic acid receptors which are
located in the upper and lower respiratory tract, respectively
(Childs et al., 2009) whereas sH1N1 binds preferentially to α2,6-
linked sialyl sequences. It has been suggested that increased lower
respiratory tract tropism by H1N1pdm may exacerbate disease
(Childs et al., 2009; Shieh et al., 2010). Furthermore, severe cases
of H1N1pdm infection are characterized clinically by rapidly
progressing lower respiratory tract disease leading to multilobar
pneumonia, the development of acute respiratory distress
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syndrome, and impaired lung function (Kumar et al., 2009; Uyeki
et al., 2009; Napolitano et al., 2009; Hui et al., 2010). Strikingly, the
immune response proﬁle of human H1N1pdm infection differs
from that of previously circulating sH1N1, where H1N1pdm
infection is associated with stronger, sustained inﬂammatory
responses and pathogenic immune dysregulation (Shieh et al.,
2010; Lee et al., 2011a, 2011b). Animal models of H1N1pdm
infection have similarly shown increased lung inﬂammation and
pathogenicity compared to sH1N1 infection (Rowe et al., 2010;
Itoh et al., 2009; Huang et al., 2011; Fang et al., 2012).
The respiratory epithelium is the primary site of inﬂuenza
infection (Taubenberger and Morens 2008) with a pivotal role in
establishing the inﬂammatory microenvironment to orchestrate
broader pulmonary inﬂammation (Tam et al., 2011; Bals and
Hiemstra 2004; Kato and Schleimer 2007; León et al., 2013;
Sanders et al., 2011). Following inﬂuenza A infection, epithelial cells
release cytokines such as interleukin-6 (IL-6), chemokine (C-X-C
motif) ligand 8 (CXCL8/IL-8), and chemokine (C-X-C motif) ligand 10
(CXCL10/IP-10) (León et al., 2013; Sanders et al., 2011), resulting in
localized inﬂammatory activation of surrounding tissues (Teijaro
et al., 2011), the recruitment of innate immune cells (Kato and
Schleimer 2007; León et al., 2013; Sanders et al., 2011; Teijaro et al.,
2011), and further ampliﬁcation of the inﬂammatory response (León
et al., 2013). Importantly, the respiratory epithelial cell response to
inﬂuenza A infection is strain-dependent, and robust inﬂammatory
microenvironments induced by certain virus strains, most notably
avian H5N1 inﬂuenza A, may play critical roles in exacerbating
pulmonary inﬂammation (Chan et al., 2005; Hui et al., 2011). In the
case of H1N1pdm infection, the contribution of respiratory epithe-
lial cells to pulmonary inﬂammation remains unclear (Chan et al.,
2010; Patel et al., 2011; Mukherjee et al., 2011; Zeng et al., 2011).
Inﬂuenza A virus entry into the cell is mediated by host cell
endocytosis (Lakadamyali et al., 2004). Virions are internalized and
trafﬁcked along the endocytic pathway until they reach acidiﬁed
late endosomes. pH-dependent changes following virion internali-
zation allows for conformational changes in the viral hemagglutinin
(HA) to mediate fusion of viral and endosomal membranes and
allow the release of internal virion contents to the cell cytosol
(Lakadamyali et al., 2004; Skehel and Wiley, 2000). Importantly, the
viral entry process can initiate widespread changes in host cell gene
expression. First, inﬂuenza A viruses activate host cell signaling
cascades to promote endocytosis and direct late endosomal sorting
(Eierhoff et al., 2010; Ehrhardt et al., 2006; Sieczkarski et al., 2003;
Marchant et al., 2010). In addition, the virus inadvertently activates
various innate pathogen sensing pathways throughout the entry
process (Le Gofﬁc et al., 2007; Guillot et al., 2005; Sharma et al.,
2011; Rehwinkel et al., 2010; Zhang et al., 2011; Shapira et al., 2009;
Xu et al., 2012). Critically, many host-pathogen interactions which
occur during entry produce strain-speciﬁc changes in host gene
expression (Zheng and Bevilacqua, 2004; Nallagatla et al., 2011; Liu
et al., 2010; Davis et al., 2012; Saito et al., 2008) and inﬂammatory
responses elicited by viral entry may differ between inﬂuenza A
viruses.
Early epithelial cell responses in the lower airways may play
critical roles in exacerbating pulmonary inﬂammation during
H1N1pdm infection (Childs et al., 2009; Shieh et al., 2010; Tam
et al., 2011; Bals and Hiemstra, 2004; Kato and Schleimer 2007; León
et al., 2013; Sanders et al., 2011), yet these responses are difﬁcult to
detect using in vivo infection models. To overcome this limitation,
we analyzed host responses to H1N1pdm and sH1N1 infection in
normal human bronchial epithelial cells (NHBECs) in vitro, primary
human cells derived from the tracheal/bronchial epithelia. Here, we
report H1N1pdm induced a robust, acute inﬂammatory gene signa-
ture distinct from sH1N1, featuring neutrophil-recruiting chemo-
kines (chemokine (C-X-C motif) ligand 1 (CXCL1), CXCL8) and
Th1/Th17-response associated cytokines (CXCL10, interleukin-36γ
(IL-36γ)). Subsequent mechanistic studies revealed H1N1pdm directly
elicited inﬂammatory gene expression during viral entry after mem-
brane fusion and implicated host vRNA sensors in the distinct
response to H1N1pdm. Thus, our study revealed a robust and acute
inﬂammatory gene signature to H1N1pdm infection in NHBECs
in vitro with important implications for H1N1pdm pathogenesis.
Results
H1N1pdm and sH1N1 infect NHBECs in vitro with similar replication
kinetics
Given the critical role lower airway epithelial cells may play in
H1N1pdm-induced inﬂammation (Shieh et al., 2010; Taubenberger
and Morens 2008; Tam et al., 2011; Bals and Hiemstra 2004; Kato
and Schleimer 2007; León et al., 2013; Sanders et al., 2011), we ﬁrst
investigated sH1N1 and H1N1pdm infection kinetics in normal
human bronchial epithelial cells (NHBECs) which are primary
human cells derived from the tracheal/bronchial epithelia. Speciﬁ-
cally we investigated differences in viral burden and host cell
damage, factors which could contribute to increased H1N1pdm
pathogenesis.
NHBECs were infected with 0.9 MOI of either H1N1pdm virus A/
Mexico/4108/2009 (H1N1) or sH1N1 virus A/Brisbane/59/2007
(H1N1). Changes in vRNA levels were used to monitor viral replica-
tion. Total cellular RNA was collected at the speciﬁed time-points
and the level of vRNA gene segment 7 was quantiﬁed by qRT-PCR,
normalized to 1.0105 copies of housekeeping gene GAPDH mRNA.
Low initial levels of vRNA were detected in NHBECs at the earliest
time-point of 2 h post-infection (pi). vRNA levels for both viruses
increased approximately 10-fold at 6 h pi and again at 12 h pi before
plateauing between 12–24 h pi (Fig. 1A). Peak vRNA levels for both
viruses were detected at 12 h pi, with approximately 8.0105 vRNA
copies detected during H1N1pdm infection and 9.0105 vRNA
copies during sH1N1 infection. Notably, no signiﬁcant differences
in vRNA levels were detected between H1N1pdm and sH1N1 viruses
at any of the time-points tested.
NHBEC cell viability remained at 100% following infection with
either sH1N1 or H1N1pdm viruses until 24 h pi at which point the
cell viability was reduced to 60-80% (Fig. 1B). A trend of greater
viability reduction during sH1N1 infection was consistently
observed, although differences were not statistically signiﬁcant.
Typical host cell viability after sH1N1 infection was 60–70%
relative to uninfected controls, compared to 80% viability in host
cells infected with H1N1pdm in the 24 h to 72 h time period. As an
assay control for all viability experiments, cells were treated with
5 μM Cytochalasin B. Cytochalasin B treatment consistently caused
a reduction in cell viability to approximately 70% relative to
untreated cells. In summary, we found NHBECs were similarly
permissive to both sH1N1 and H1N1pdm replication in vitro.
H1N1pdm elicits robust acute inﬂammatory signature in NHBECs
distinct from sH1N1
Severe H1N1pdm infection is associated with excessive pul-
monary inﬂammation (Shieh et al., 2010; Lee et al., 2011b;
Bermejo-Martin et al., 2009) but the role of the respiratory
epithelium in modulating these inﬂammatory responses remains
unclear (Chan et al., 2010; Patel et al., 2011; Mukherjee et al., 2011;
Zeng et al., 2011). To deﬁne the genetic signature of human
respiratory epithelial cells during H1N1pdm infection and the
differences between H1N1pdm and sH1N1 infections, we infected
NHBECs with 0.9 MOI of either H1N1pdm virus A/Mexico/4108/
2009 (H1N1) or sH1N1 virus A/Brisbane/59/2007 (H1N1). Total
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Fig. 1. H1N1pdm and sH1N1 viruses infected NHBECs in vitro have similar replication kinetics. NHBECs were infected with 0.9 MOI H1N1pdm virus A/Mexico/4108/2009
(H1N1) or sH1N1 virus A/Brisbane/59/2007 (H1N1). For vRNA measurement, total cellular RNA was collected and viral mRNA segment 7 copy numbers were quantiﬁed by
qRT-PCR, normalized to host cell GAPDH mRNA copy numbers. n¼3 for each time-point. Error bars denote 71 standard deviation (A). For cell viability, cells were incubated
with 500 μg/mL MTT, lysed, and absorbance was measured at 570 nm–670 nm. Viability of infected cells was reported as percentage of mock infected cell viability.
Cytochalasin B was included as a control for detection of reduced cell viability. Each condition was assayed in triplicate. Error bars denote 71 standard deviation.
p-valueo0.05¼*, p-value o0.01¼**. Results are representative of three independent experiments (B).
Fig. 2. H1N1pdm triggers stronger acute inﬂammatory gene expression in NHBECs than sH1N1. Global gene expression proﬁling of host responses in NHBECs at 3 h and 24 h
pi with either 0.9 MOI A/Mexico/4108/2009 (H1N1) or A/Brisbane/59/2007 (H1N1). n¼3 for each time-point. Probes for signiﬁcantly differentially regulated genes
(p-valueo0.05, fold change Z1.5 fold; total number of genes: 1031) were subjected to one-way hierarchical clustering analysis (Pearson's correlation) and clusters were
functionally annotated using DAVID Bioinformatics Resource v6.7. The most prominent functional groups are indicated for each cluster (A). Stylized model of immune
activation during H1N1pdm or sH1N1 infection of NHBECs. Approximated gene expression proﬁles for the inﬂammatory response (red) and interferon response (black)
clusters. Numeric values denote average fold changes for each cluster at 3 h pi and 24 h pi (B).
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cellular RNA was then collected at 3 h and 24 h pi for global gene
expression analysis by microarray.
Global clustering analysis of mRNA expression data by Pearson's
correlation was performed for all signiﬁcantly differentially regu-
lated genes (p-valueo0.05, fold change Z |1.5 fold|; total number of
genes: 1031) using MultiExperiment Viewer v4.6.2. Two clearly
delineated clusters of upregulated genes were identiﬁed (Fig. 2A).
Detailed summaries of the most prominent functional groups in
each of the two clusters are included in Fig. S1. The ﬁrst cluster was
upregulated at 3 h pi only during H1N1pdm infection and was
strongly enriched in genes encoding inﬂammatory cytokines such
as CXCL8, IL-6, and IL-36γ, as well as inﬂammatory signaling
intermediates of the Nf-κB (NFKB1, NFKB2, NFKBIA, RIPK2), Jak-
STAT (SOCS1, SOCS2, STAM), and TLR (TICAM1) signaling pathways.
As a whole, the inﬂammatory response gene cluster was upregu-
lated approximately 2.6 fold (1.4 log2) by H1N1pdm infection
compared to only 1.3 fold (0.4 log2) by sH1N1 infection at 3 h pi
(Fig. 2B). Interestingly, while upregulation of inﬂammatory signal-
ing intermediates had largely dissipated by 24 h pi, expression of
many inﬂammatory cytokine genes, including CXCL8, IL-6, and IL-
36γ, remained elevated. The second cluster of upregulated genes
was induced by both H1N1pdm and sH1N1 infection at 24 h pi and
was heavily enriched in antiviral and interferon response genes
which included MX1, ISG15, and IFI44. The magnitude of upregula-
tion for genes in this cluster was similar for both viruses, with
average increases in interferon response gene expression of
approximately 3.5-fold at 24 h post-H1N1pdm infection and 2.8-
fold at 24 h post-sH1N1 infection. Thus, global analysis revealed a
much stronger acute inﬂammatory response to H1N1pdm infection
than sH1N1 infection, which was gradually replaced by a dominant
interferon response by 24 h pi.
To complement our hierarchical clustering analysis, we also
performed gene ontology classiﬁcation of all signiﬁcantly upregu-
lated genes (p-valueo0.05, fold change Z1.5 fold) at 3 h and 24 h
pi with H1N1pdm or sH1N1. Gene Ontology (GO) Biological
Process, PANTHER Biological Process, and Kyoto encyclopedia of
genes and genomes (KEGG) Pathway databases were used for
classiﬁcation. Similar to above, H1N1pdm infection led to the
signiﬁcant upregulation of more immune response genes (34) than
sH1N1 (1) at 3 h pi (GO0006955) and, in particular, inﬂammatory
response genes (H1N1pdm: 25, sH1N1: 3) (GO0006954) (Table
S1). Moreover, genes associated with inﬂammatory signaling
cascades such as NF-κB (BP00115) and Jak-STAT (hsa04630) were
signiﬁcantly upregulated in greater numbers by H1N1pdm com-
pared to sH1N1. We also found that H1N1pdm led to the rapid
upregulation of genes involved in apoptosis (H1N1pdm: 32,
sH1N1: 4) (GO0006915) which were predominantly intermediates
of the TNF-α/NF-κB signaling cascade. The individual genes sig-
niﬁcantly upregulated by H1N1pdm at 3 h pi and included in Table
S2 and classiﬁcations are listed in Table S2.
Detailed analysis of H1N1pdm-induced inﬂammatory gene
expression at 3 h pi revealed prominent upregulation of neutro-
phil recruiting chemokines including CXCL1 and CXCL8, as well as
Th1/Th17 activating cytokines including IL-36γ and CXCL10. We
also found H1N1pdm triggered broad upregulation of pleiotropic
inﬂammatory cytokines and inﬂammatory signaling cascade inter-
mediates (Fig. 3A). CXCL1, CXCL8, CXCL10, IL-6, and IL-36γ mRNA
expression levels were next quantiﬁed by qRT-PCR to validate our
global analyses. H1N1pdm infection consistently induced greater
upregulation of all cytokines measured at both 3 and 24 h pi
(Fig. 3B). IL-36γ and CXCL8 were again the most strongly upregu-
lated genes at 3 h pi with H1N1pdm, with increases in expression
of 206-fold and 147-fold over baseline, respectively.
To determine whether increased inﬂammatory gene expres-
sion led to secretion of inﬂammatory cytokines in infected
NHBECs, cell culture supernatants were collected at 3 h pi and
protein levels of CXCL1 and CXCL8 were measured by ELISA.
Consistent with our mRNA expression data, H1N1pdm infected
cells secreted signiﬁcantly higher CXCL1 (116 pg/mL) and CXCL8
(33 pg/mL) than sH1N1 infected cells (CXCL1: 52 pg/mL, CXCL8:
14 pg/mL) (Fig. 3C).
To determine the effect of infection dose on the speciﬁc host
response to H1N1pdm, we also investigated inﬂammatory cyto-
kine mRNA expression at 3 h pi with increasing doses of either
sH1N1 or H1N1pdm. We found H1N1pdm infection consistently
generated stronger inﬂammatory signatures than sH1N1 infec-
tion at all doses tested. For both viruses, the magnitude of the
host inﬂammatory response was dose-dependent (Fig. S2). Taken
together, our ﬁndings provided evidence at the mRNA and
protein level that H1N1pdm infection produced a robust, acute
inﬂammatory gene signature in NHBECs, distinct from sH1N1
infection.
H1N1pdm directly induces acute inﬂammatory gene signature
Our initial in vitro studies indicated H1N1pdm induced stronger
acute inﬂammatory gene expression than sH1N1 in NHBECs. We
next investigated whether inﬂammatory gene expression was
directly triggered by host interaction with the virus or if the
secretion of secondary inﬂammatory mediators mediated this
response. To determine if protein secretion was required for the
induction of an acute inﬂammatory signature, we pretreated
NHBECs with 10 μg/mL brefeldin A to block protein secretion
and secondary mediator signaling, then subsequently infected
with 0.9 MOI of either A/Mexico/4108/2009 (H1N1) or A/Bris-
bane/59/2007 (H1N1).
To evaluate the effect of protein secretion blockade on the acute
inﬂammatory response, mRNA levels for CXCL1, CXCL8, CXCL10,
and IL-36γ were measured, at 3 h pi. H1N1pdm infection resulted
in strong, equivalent upregulation of all four genes with and
without brefeldin A treatment. In untreated and brefeldin A
pretreated cells respectively, H1N1pdm generated 41-fold and
59-fold increases in IL-36γ expression, 26-fold and 35-fold
increases in CXCL8 expression, 11-fold and 13-fold increases in
CXCL10 expression, and equivalent 12-fold increases in CXCL1
expression. Critically, differences in inﬂammatory gene expression
between H1N1pdm and sH1N1 infections were statistically sig-
niﬁcant in both untreated and brefeldin A treated NHBECs. To
verify that brefeldin A treatment blocked protein secretion during
infection, we quantiﬁed CXCL1 and CXCL8 levels in cell culture
supernatants collected at 3 h pi. As expected, pretreatment with
brefeldin A blocked secretion such that CXCL1 and CXCL8 levels
were equivalent to levels detected from mock infected untreated
NHBECs (Fig. 4B). We also conﬁrmed equivalent amounts of sH1N1
and H1N1pdm virus infected NHBEC by qRT-PCR quantiﬁcation of
intracellular vRNA at 3 h pi (Fig. 4C). Overall, these results
suggested the acute inﬂammatory gene signature H1N1pdm
infection was independent of secondary inﬂammatory mediators
and in direct response to host interaction with the virus.
The acute inﬂammatory gene signature of H1N1pdm infection is
initiated downstream of the virus-host membrane fusion event
Our above data suggested H1N1pdm virus infection directly
caused stronger acute inﬂammatory gene expression in NHBECs
than sH1N1. We next sought to investigate the molecular events
required during H1N1pdm infection to elicit the more robust
inﬂammatory response. We ﬁrst investigated potential host virus
interactions at the cell surface and during H1N1pdm internaliza-
tion. For this we treated H1N1pdm and sH1N1 viruses with
formalin, a cross-linking agent which prevents membrane fusion
but allows for virus internalization (Budimir et al., 2012). Thus,
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formalin inactivated viruses do not have access to the intracellular
compartment. NHBECs were stimulated with 0.9 MOI equivalent of
formalin-inactivated A/Mexico/4108/2009 (H1N1) or A/Brisbane/
59/2009 (H1N1) and inﬂammatory gene expression was measured
at 3 h post-stimulation. Both sH1N1 and H1N1pdm formalin-
inactivated viruses produced modest and equivalent increases in
CXCL1, CXCL8, CXCL10, and IL-36γ mRNA levels, with 2-5 fold
increases in expression detected for all four genes (Fig. 5).
Importantly, no signiﬁcant differences in expression were detected
between sH1N1 and H1N1pdm stimulation for any of the genes
tested. This result suggested host-pathogen interactions upstream
of membrane fusion were not responsible for the acute inﬂamma-
tory gene signature speciﬁc to H1N1pdm infection.
We next investigated the roles of virus-host membrane fusion
and the internal virion release to the cytosol in the host response
to H1N1pdm and establishment of an inﬂammatory gene
Fig. 3. The acute inﬂammatory gene signature of H1N1pdm is enriched in neutrophil-recruiting and Th1/Th17-response associated genes. Expression data of inﬂammatory
response genes signiﬁcantly upregulated at 3 h pi with H1N1pdm, proﬁled over the course of infection. Inﬂammatory response genes were classiﬁed by immune function:
Neutrophil Recruitment, Th1/Th17 Recruitment, Pleiotropic Inﬂammatory Cytokines, and Inﬂammatory Signaling Intermediates. Signiﬁcant differences between H1N1pdm
and sH1N1 expression at 3 h pi are denoted by an asterisk (p-valueo0.05, fold-change Z1.5¼n) (A). Gene expression data validation by qRT-PCR for CXCL1, CXCL8, CXCL10,
and IL-36γ mRNA, expression data reported as fold change over expression at baseline (0 h). Average values (n¼3) are reported with þ1 standard deviation indicated by
vertical error bars (B). Protein secretion levels for CXCL1 and CXCL8 in infected cell supernatants as measured by ELISA. Average values are reported, with n¼3 for each
group. Vertical error bars indicate þ1 standard deviation (C). Asterisks above data bars indicate signiﬁcant difference relative to mock controls (3 h). Asterisks over
horizontal lines indicate signiﬁcant difference between H1N1pdm and sH1N1 infections. p-value o0.05¼n, p-value o0.01¼nn.
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signature. For these experiments, viruses were heat-inactivated
such that the viruses were capable of viral entry by membrane
fusion but incapable of replication (Budimir et al., 2012; Wang
et al., 2008). NHBECs were stimulated with 0.9 MOI equivalent of
heat-inactivated A/Mexico/4108/2009 (H1N1) or A/Brisbane/59/
2009 (H1N1) and gene induction was determined as above.
Stimulation with heat-inactivated H1N1pdm resulted in signiﬁ-
cantly increased expression of all measured genes. Fold changes in
expression over baseline were 43-fold for IL-36γ, 23-fold for
CXCL8, 10-fold for CXCL1, and 4-fold for CXCL10 at 3 h post
stimulation. In contrast, heat-inactivated sH1N1 only produced
modest upregulation of those same genes (IL-36γ: 8-fold, CXCL8:
4-fold, CXCL1: 3-fold, CXCL10: 1.5-fold) (Fig. 6A). Critically,
H1N1pdm elicited signiﬁcantly higher expression of CXCL1, CXCL8,
and IL-36γ than sH1N1. Thus, H1N1pdm was able to induce
stronger inﬂammatory gene expression independent of viral
replication when membrane fusion and cytosolic access were
allowed. As control, we veriﬁed that equivalent amounts of
sH1N1 and H1N1pdm virus were internalized upon NHBEC
stimulation by qRT-PCR quantiﬁcation of intracellular vRNA at
3 h pi (Fig. 6B). Similar results were obtained with β-
propiolactone inactivation of H1N1pdm and sH1N1 inﬂuenza A
viruses, which also prevents viral replication but allows
membrane fusion (Budimir et al., 2012) (Fig. S3). Taken together,
our results suggested that the robust, acute inﬂammatory gene
signature of H1N1pdm infection occurred during viral entry
downstream of membrane fusion and was independent of viral
replication.
H1N1pdm vRNA is a more potent inducer of inﬂammatory gene
expression than sH1N1 vRNA
Inactivated virus stimulation of NHBECs revealed membrane fusion
was required to initiate the acute inﬂammatory gene signature of
H1N1pdm. Inﬂuenza vRNA is released to the cell cytosol by membrane
fusion and is an important trigger of host innate responses (Le Gofﬁc
et al., 2007; Guillot et al., 2005; Sharma et al., 2011; Rehwinkel et al.,
2010; Zhang et al., 2011). Since innate sensing of viral RNA is partially
sequence dependent (Zheng and Bevilacqua 2004; Nallagatla et al.,
2011; Davis et al., 2012; Saito et al., 2008), we hypothesized that
inherent differences in vRNA motifs between H1N1pdm and sH1N1
viruses were responsible for the stronger inﬂammatory gene expres-
sion observed early during H1N1pdm infection.
NHBECs were then transfected with a ﬁnal concentration of
100, 300, or 500 ng/mL vRNA extracted from A/Mexico/4108/2009
(H1N1) or A/Brisbane/59/2007 (H1N1) egg allantoic stocks. For
Fig. 4. H1N1pdm virus directly induces stronger acute inﬂammatory gene expression in NHBECs than sH1N1. NHBECs were pretreated with 10 μg/mL brefeldin A for 1 h
prior to infection with either 0.9 MOI A/Mexico/4108/2009 (H1N1) or A/Brisbane/59/2007 (H1N1). Total cellular RNA was collected at 0 h (baseline) and 3 h pi and mRNA
levels of inﬂammatory cytokines CXCL1, CXCL8, CXCL10, and IL-36γ were quantiﬁed by qRT-PCR, reported as fold changes over expression in baseline (0 h) controls. (A). To
verify inhibition of inﬂammatory cytokine secretion, cell supernatants were collected at 3 h pi for secreted cytokine protein quantiﬁcation by ELISA. (B). To verify infection
with equivalent quantities of sH1N1 or H1N1pdm virus, viral mRNA segment 7 copy numbers were quantiﬁed by qRT-PCR, normalized to host cell GAPDH mRNA (C). n¼3 for
each group. Error bars denote þ1 standard deviation. p-value o0.05¼n, p-value o0.01¼nn. Asterisks above data bars denote signiﬁcant difference relative to mock controls
(3 h). Asterisks over horizontal lines indicate signiﬁcant difference between H1N1pdm and sH1N1 infections.
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mock stimulations, cells were transfected with RNA extracted from
uninfected egg allantoic ﬂuid (500 ng). Cells were also transfected
with 1 μg/mL Poly I:C as an assay control. Cytosolic stimulation by
inﬂuenza vRNA transfection led to the speciﬁc upregulation of
CXCL10, IL-6, and IFN-β mRNA in a dose-dependent manner.
Importantly, H1N1pdm vRNA consistently induced greater upre-
gulation of these genes than sH1N1 vRNA; at the highest vRNA
dose of 500 ng/mL, changes in CXCL10, IL-6, and IFN-β expression
over baseline were 156-fold, 31-fold, and 18-fold after H1N1pdm
transfection, but only 49-fold, 11-fold, and 9-fold after sH1N1
transfection (Fig. 7A). As control, qRT-PCR showed equal amounts
of sH1N1 and H1N1pdm RNA had gained entry into the cells
(Fig. 7B). These results suggested a partial role for cytosolic vRNA
sensors in generating the stronger inﬂammatory response to
H1N1pdm infection.
Discussion
Severe cases of H1N1pdm infection are characterized by epithe-
lial cell activation/damage, pulmonary inﬂammation and impaired
lung function (Shieh et al., 2010; Mauad et al., 2010; Kumar et al.,
2009; Uyeki et al., 2009; Napolitano et al., 2009) and the mechan-
isms of epithelial cell activation leading to severe disease remain
unknown. Here we have shown that H1N1pdm virus infection of
human primary bronchial epithelial cells in vitro directly induced a
Fig. 5. H1N1pdm and sH1N1 viruses unable to fuse with host cell membrane have equivalent modest upregulation of inﬂammatory gene expression. NHBECs were
stimulated with 0.9 MOI equivalent formalin-inactivated H1N1pdm virus A/Mexico/4108/2009 (H1N1) or formalin-inactivated sH1N1 virus A/Brisbane/59/2007 (H1N1).
Total cellular RNA was collected at baseline (0 h) and 3 h post-stimulation, and CXCL1, CXCL8, CXCL10, and IL-36γ mRNA expression was measured by qRT-PCR. Results are
expressed as fold changes over expression in baseline (0 h) controls. Reported values for each time point are the average of three samples (n¼3) with þ1 standard deviation
indicated by vertical error bars. p-value o0.05¼n. Asterisks above data bars indicate signiﬁcant difference relative to mock controls (3 h). Asterisks over horizontal lines
indicate signiﬁcant difference between inactivated H1N1pdm and sH1N1 stimulations.
Fig. 6. Infection with membrane fusion competent H1N1pdm inactivated virus leads to signiﬁcant inﬂammatory gene induction. NHBECs were stimulated with 0.9 MOI
equivalent heat-inactivated H1N1pdm virus A/Mexico/4108/2009 (H1N1) or heat-inactivated sH1N1 virus A/Brisbane/59/2007 (H1N1). Total cellular RNA was extracted and
expression of CXCL1, CXCL8, CXCL10, and IL-36γ mRNA was measured by qRT-PCR. Results are shown as fold changes over expression in baseline (0 h) controls (A). To verify
stimulation with equivalent quantities of sH1N1 or H1N1pdm virus, viral mRNA segment 7 copy numbers were quantiﬁed by qRT-PCR, normalized to host cell GAPDH mRNA
(B). Average values (n¼3) reported with þ1 standard deviation indicated by vertical error bars. p-value o0.05¼n. Asterisks above data bars indicate signiﬁcant difference
relative to mock controls (3 h). Asterisks over horizontal lines indicate signiﬁcant difference between inactivated H1N1pdm and sH1N1 stimulations.
S.G. Paquette et al. / Virology 448 (2014) 91–103 97
robust, acute inﬂammatory gene signature enriched in neutrophil
recruiting chemokines (CXCL1, CXCL8) and Th1/Th17-response
associated cytokines (CXCL10, IL-36γ) which was not seen with
sH1N1 infection. Furthermore, we also showed that the H1N1pdm
inﬂammatory phenotype was downstream of virus-host membrane
fusion and that H1N1pdm vRNA transfection yielded stronger
inﬂammatory gene up-regulation of a subset of genes in vitro. Our
ﬁndings reveal an acute inﬂammatory gene signature speciﬁc to
H1N1pdm virus entry, implicating the respiratory epithelium in
exacerbation of pulmonary inﬂammatory during severe H1N1pdm
infection. These ﬁndings are signiﬁcant to the investigation of the
immediate early events of inﬂuenza virus infection as studying the
events following virus infection remains a signiﬁcant challenge
in vivo. Our results utilizing primary human epithelial cells and the
identiﬁcation of the direct H1N1pdm induction of an inﬂammatory
gene signature may be extrapolated to the initial epithelial cellular
reactions upon H1N1pdm infection in the human trachea and
bronchi. Furthermore, the dependence on virus-host cell fusion
suggests viral entry and membrane fusion to be possible therapeu-
tic targets for the treatment of severe H1N1pdm infection.
Respiratory epithelial cells are both the ﬁrst and most fre-
quently exposed cells to the inﬂuenza virus during infection,
suggesting a central role in establishing broader pulmonary
immune responses (Tam et al., 2011; Bals and Hiemstra 2004;
Kato and Schleimer 2007; León et al., 2013; Sanders et al., 2011).
The gene signature we detected following H1N1pdm infection
in vitro was highlighted by strong upregulation of genes involved
in neutrophil recruitment (CXCL1, CXCL8) and Th1/Th17-type
responses (CXCL10, IL-36γ) consistent with results of human and
animal H1N1pdm investigations (Mauad et al., 2010; Itoh et al.,
2009; León et al., 2013; Bermejo-Martin et al., 2009; Paquette
et al., 2012; Cho et al., 2012; Frisullo et al., 2011; Marcelin et al.,
2011; Huang et al., 2012) and was not seen in sH1N1 infection.
León et al. recently proﬁled the infectome of H1N1pdm infection
in ferrets and identiﬁed a cluster of inﬂammatory genes upregu-
lated in the lungs of ferrets at Day 5 pi (León et al., 2013). Some of
the most strongly upregulated genes in vivo, CXCL8, CXCL10, and
IL-6, were genes we also found to be preferentially induced during
H1N1pdm entry in vitro. Similarly, inﬂammatory cytokines CXCL1
and chemokine (C-X-C motif) ligand 2 (CXCL2), along with CXCL10
and IL-6, were strongly upregulated both during our in vitro study
as well in the lungs of mice infected with H1N1pdm (Day 3 pi)
(Itoh et al., 2009; Paquette et al., 2012). Excessive Th1/Tc1-type
responses and neutrophil inﬁltration have been heavily implicated
in H1N1pdm human pathogenesis (Mauad et al., 2010; Bermejo-
Martin et al., 2009; Cho et al., 2012; Frisullo et al., 2011; Marcelin
et al., 2011; Huang et al., 2012). Furthermore, cytokine proﬁling
studies in patients hospitalized with severe H1N1pdm infection
have found CXCL8, IL-6, and Th1/Th17 associated cytokines to be
most frequently associated with severe disease (Bermejo-Martin
et al., 2009; Paquette et al., 2012). Pulmonary responses to
inﬂuenza infection in vivo are mediated by multiple immune and
non-immune cell populations (Taubenberger and Morens 2008;
León et al., 2013; Teijaro et al., 2011) and the precise contributions
of individual cell populations to H1N1pdm-induced pulmo-
nary inﬂammation remain to be deﬁned. Accordingly, cytokines
Fig. 7. Intracellular stimulation with H1N1pdm vRNA induces a partial inﬂammatory gene program. NHBECs were transfected with 100, 300, or 500 ng puriﬁed vRNA of A/
Mexico/4108/2009 (H1N1) or A/Brisbane/59/2007 (H1N1) origin, or RNA from uninfected allantoic ﬂuid (500 ng) as mock. Total cellular RNA was collected for gene
expression analysis and conﬁrmation of transfection at baseline (0 h) and 3 h post-stimulation. CXCL1, CXCL8, CXCL10, IL-6, IL-36γ, and IFN-βmRNA expressionwas measured
by qRT-PCR, reported as fold changes in expression over baseline (0 h) controls (A). Viral mRNA segment 7 copy numbers were quantiﬁed by qRT-PCR for conﬁrmation of
transfection (B). Reported values for each time point are the average of three samples (n¼3) with þ1 standard deviation indicated by vertical error bars. p-value o0.05¼n.
Asterisks over horizontal lines indicate signiﬁcant difference between H1N1pdm- or sH1N1-derived vRNA transfections.
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detected in vivo may not be entirely generated from the respira-
tory epithelial cell population. However, close agreement between
our in vitro gene signature and previous in vivo response proﬁles
suggests the epithelial response to H1N1pdm entry to be detect-
able in vivo. Furthermore, this ﬁnding supports the possibility that
respiratory epithelial cells may play a role orchestrating inﬂam-
matory events following initial infection through the release
of inﬂammatory mediators but may not be the only source of
cytokine production as other cell types begin to respond to the
epithelial cell signals. As well, identiﬁcation of the direct acute
inﬂammatory phenotype in vivo may reﬂect continued and
expanding infection of new epithelial cells as the virus moves
throughout the respiratory tract thereby leading to a more
sustained inﬂammatory signature. This, together with the putative
role of epithelial cells in initiating pulmonary inﬂammation (Tam
et al., 2011; Bals and Hiemstra 2004; Kato and Schleimer 2007;
León et al., 2013; Sanders et al., 2011), may recommend the
inﬂammatory cytokines identiﬁed here as suitable therapeutic
targets for immunomodulation and/or biomarkers of severe
H1N1pdm infection.
Previous in vitro studies have reported H1N1pdm infection
caused either similar or weaker immune responses than seasonal
inﬂuenza A, which is in disagreement with our ﬁndings that
showed the direct induction of an acute inﬂammatory signature
(Chan et al., 2010; Patel et al., 2011; Mukherjee et al., 2011; Zeng
et al., 2011). Importantly, our study focused on the immediate
responses to viral entry in contrast to previous studies that
investigated host responses in cells with established infection.
Cytosolic sensing of replication intermediates and accumulation of
viral protein both trigger innate responses in respiratory epithelial
cells (Ehrhardt et al., 2006; Marjuki et al., 2006; Ichinohe et al.,
2010) and may have masked the direct acute host responses
during previous studies. In support of this hypothesis, global gene
expression analysis in our study suggested sH1N1 and H1N1pdm
generated similar interferon-dominated responses at the later
stages of infection at the time point of 24 h pi. Prior studies which
reported attenuated inﬂammatory responses to H1N1pdm infec-
tion were performed in immortalized cell lines (Patel et al., 2011;
Mukherjee et al., 2011; Zeng et al., 2011) which may not be
representative of normal human respiratory epithelial cells. Pre-
vious in vitro studies in primary respiratory epithelial cells have
not reported attenuation (Chan et al., 2010). These differences in
experimental sampling and design may explain why we are ﬁrst to
identify H1N1pdm as a stronger inducer of inﬂammation than
sH1N1 in vitro.
Here we found only membrane fusion competent viruses were
able to elicit the acute inﬂammatory gene signature of H1N1pdm,
a ﬁnding which prompted us to investigate internal virion contents
as potential triggers of the inﬂammatory signature. We found
H1N1pdm vRNA to be a more potent inducer of inﬂammatory gene
expression than sH1N1. Host RNA sensors have been implicated in
initiating inﬂammatory gene expression during inﬂuenza infection
(Takeuchi and Akira 2010). In the context of our study, the potential
contributions of TLR3 and PKR are of particular interest. Both
receptors are constitutively expressed (García et al., 2006; Akira
and Takeda 2004) and modulate expression of many inﬂammatory
genes we found to be strongly upregulated during H1N1pdm entry
in vitro, including CXCL1 (Matsukura et al., 2006; Yamashita et al.,
2005), CXCL8 (Le Gofﬁc et al., 2007; Matsukura et al., 2006; Gern
et al., 2003), IL-6 (Le Gofﬁc et al., 2007; Matsukura et al., 2006), and
IL-36γ (Chustz et al., 2011). Although we found H1N1pdm vRNA
initiated stronger innate host responses than sH1N1 vRNA, vRNA
stimulation did not completely mimic the broader response proﬁle
observed during infection. Rather, we found that vRNA stimulation
predominantly led to strong expression of interferon response factor
(IRF)-associated cytokines IL-6, IFN-β, and CXCL10 (Taniguchi et al.,
2001). Our stimulation experiments investigated the effect of vRNA
on the host response in isolation. Since inﬂuenza viruses activate
multiple signaling cascades during viral attachment and entry which
modulate the host immune response (Eierhoff et al., 2010; Ehrhardt
et al., 2006; Sieczkarski et al., 2003; Marchant et al., 2010) it is
possible that vRNA sensing is only a part of the stimulatory event
which leads to the identiﬁed inﬂammatory phenotype in respiratory
epithelial cells identiﬁed in this study. This hypothesis is supported
by previous reports that simultaneous activation of innate RNA
sensors in the presence of other proinﬂammatory stimuli results in
synergistic ampliﬁcation of inﬂammatory cytokine expression
(Chustz et al., 2011). Thus, H1N1pdm vRNA may have a broader
effect on inﬂammatory gene expression in the context of live virus
infection. Importantly, further studies are required to conclusively
determine whether vRNA sensing pathways alone mediate the acute
inﬂammatory gene signature of H1N1pdm or if additional proin-
ﬂammatory signals, such as host sensing of membrane fusion, are
required. Our data did not allow us to determine if the fusion event
itself directly inﬂuenced the epithelial inﬂammatory response. Given
previous reports of fusion inducing innate cellular responses during
viral infection (Holm et al., 2012), the direct impact of membrane
fusion on the acute H1N1pdm signature should be the focus of
future studies.
Our results imply that the H1N1pdm virus inherently pos-
sesses a molecular motif capable of instigating an inﬂammatory
phenotype which is not contained within the seasonal H1N1
virus and may serve as a therapeutic target. Current antivirals
have been designed to target various viral proteins and stages of
the viral life cycle of which includes two main classes: M2
inhibitors and neuraminidase (NA) inhibitors (Hayden 2013).
Due to the rise of antiviral resistance (Hayden 2013; Samson
et al., 2013; Whitley et al., 2013; Govorkova et al., 2013), targeting
events other than HA-receptor cleavage (NA activity) and virion
acidiﬁcation (M2 activity) may serve as an alternate therapeutic
strategy. Amantadine antiviral drugs target the M2 protein of the
inﬂuenza virus by inhibiting ion channel activity which ulti-
mately leads to disruption of viral entry and escape. Importantly,
the majority of current circulating seasonal inﬂuenza A strains
and all of inﬂuenza B strains are amantadine resistant and having
alternative antiviral drugs and drug targets is increasingly
important. Our results advocate further investigation of targeting
viral proteins involved in viral entry and membrane fusion,
including the HA protein. Currently, clinical studies are investi-
gating the efﬁcacy of inhibiting HA conformational changes
which are required for fusion (Hayden 2013). Thus, our ﬁnding
that membrane-fusion competent inactivated-H1N1pdm directly
induced an inﬂammatory gene signature may inﬂuence the
development of inﬂuenza therapeutics and prophylactics.
Furthermore, our results suggested the existence of speciﬁc
host-pathogen interaction which led to the direct induction of
the inﬂammatory phenotype and should be the focus of future
studies. Identiﬁcation of host cell intracellular receptors involved
in this interaction may uncover additional possible targets for the
development of future immunotherapeutics. While our data
suggests induction occurred during viral entry downstream of
fusion, our ﬁndings do not exclude the possibility that down-
stream viral replication events may also inﬂuence epithelial
responses in a strain-speciﬁc manner and serve as potential
therapeutic targets. The strain-speciﬁc effects of replication
should also be investigated in the future.
Here we found H1N1pdm infection of NHBECs produced a
robust, acute inﬂammatory gene signature consistent with the
clinical manifestations of severe H1N1pdm infection. Furthermore,
we established that acute inﬂammatory gene expression detected
during H1N1pdm infection was in direct response to viral entry at a
stage downstream of membrane fusion, and mediated in part by
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host sensing of vRNA. Thus, our study implicates respiratory
epithelial cells in H1N1pdm pathogenesis and suggests a critical
role for host sensing of viral entry in amplifying pulmonary
inﬂammation. Early signaling events during viral entry, as well as
the membrane fusion event itself, may serve as valuable therapeutic
targets for the treatment of severe H1N1pdm infection.
Materials and methods
Cells
Primary human bronchial epithelial cells (NHBECs) (undiffer-
entiated) have previously been used to study host responses to
viral infection in vitro (Escaffre et al., 2013; Suksatu et al., 2009;
Dinwiddie and Harrod, 2008). Cells were purchased from Lonza
(Basel, Switzerland) and subcultured as per manufacturer recom-
mended conditions in bronchial epithelial cell growth media
(BEGM; Lonza, Basel, Switzerland), which consisted of bronchial
epithelial cells basal medium supplemented with bovine pituitary
extract, hydrocortisone, human epidermal growth factor, epi-
nephrine, transferrin, insulin, retinoic acid, triiodothyronine,
genatmicin sulfate, and amphotericin-B. Subculturing conditions
were selected to prevent NHBEC differentiation. Undifferentiated
NHBECs were grown submerged in BEGM and passaged once
conﬂuence reached 80%. Low passage cells (Huang et al., 2013;
Nicoll and Coulombier, 2009; Bautista et al., 2010; Gilsdorf and
Poggensee, 2009; Childs et al., 2009; Shieh et al., 2010; Mauad
et al., 2010) were used for all experiments.
Viral Infections
All infection experiments were conducted with A/Mexico/4108/
2009 (H1N1) as representative H1N1pdm strain and A/Brisbane/
59/2007 (H1N1) as representative sH1N1 strain. All viruses were
provided by the centers for disease control and prevention ([CDC],
Atlanta, GA, USA). Both viruses were propagated in embryonated
eggs for no more than one passage. All viral stocks were tested for
the presence of endotoxin and conﬁrmed to be endotoxin free
(o0.1 EU/mL). Viral stocks were stored in liquid nitrogen and
thawed prior to use. Tissue culture infectious dose 50 (TCID50)
titers for viral stocks were determined based on infection of
Madin–Darby Canine Kidney (MDCK) Cells. Brieﬂy, viral stocks
were serially diluted (0.5 log10) in quadruplicate over MDCK cells,
cultured at 2.0104 cells/well in 96-well plates. Cells were
incubated at 37 1C and 5% CO2 for 2 h to allow for virus adsorption.
Virus was then removed and replaced with fresh assay media.
Cells were incubated for 6 days at 37 1C and 5% CO2. Supernantants
were then tested for the presence of virus by hemagglutination
assay using 0.5% (v/v) turkey red blood cells (LAMPIRE Biological
Laboratories, Pipersville, PA, USA). TCID50 values were calculated
by the Reed and Muench method. Viral RNA levels for each stock
were measured by quantitative real-time reverse-transcription
PCR (qRT-PCR) and normalized to stock TCID50/mL; all viral stocks
contained equivalent vRNA to TCID50 levels when compared using
one-way ANOVA (α¼0.05).
All infections in NHBECs were performed in 6-well or 96-well
plates at 0.9 multiplicity of infection (MOI), unless otherwise
speciﬁed. 6-well plates were seeded with 5.0104 cells/well and
96-well plates were seeded with 1.0104 cells/well. Cells were
seeded and incubated overnight prior to infection. Immediately
prior to infection, cell culture media was supplemented with 1 μg/
mL ﬁnal concentration TPCK-Trpysin. Virus was then added and
cells were incubated at 37 1C and 5% CO2 for 2 h. After adsorption,
media was replaced with fresh growth media, and cells were
incubated at 37 1C and 5% CO2 until sample collection. For protein
secretion inhibition experiments, cells were pretreated with 10 μg/
mL brefeldin A (Sigma-Aldrich, St. Louis, MO, USA) for 1 h prior to
addition of virus; sample collection was performed at 3 h pi.
Virus inactivation
Inﬂuenza viruses were formalin inactivated by incubating the
viruses in the presence of 0.02% w/v formalin for 18 h at 37 1C.
Viruses were then dialyzed against PBS (1:500) three times to
remove residual formalin, twice for 2 h at room temperature and
once overnight at 4 1C. Inﬂuenza viruses were inactivated by β-
propiolactone by incubating the viruses in the presence of 0.094%
w/v β-propiolactone for 18 h at 4 1C. Viruses were then incubated for
2 h at 37 1C to hydrolyze residual β-propiolactone. Inﬂuenza viruses
were heat inactivated by incubating viruses for 30 min at 56 1C. Heat
inactivation under these conditions yielded a replication-incompetent
virus that retained the ability to enter host cells by membrane fusion.
Virus inactivation was veriﬁed by inocuity testing in embryonated
eggs. To ensure that inactivation did not alter the ability of the virus to
bind host cell receptors or cause a signiﬁcant reduction in viral titer,
virus particle quantiﬁcationwas also performed following inactivation
by hemagglutination assay.
vRNA stimulation
Genomic vRNAwas puriﬁed from egg allantoic ﬂuid stocks of A/
Mexico/4108/2009 (H1N1) or A/Brisbane/59/2007 (H1N1) by
RNEasy Mini Kit (Qiagen, Hilden, Germany). Transfections of
NHBECs were performed in 6-well plates. Six-well plates were
seeded with 2.0105 cells/well and incubated overnight prior to
transfection. NHBECs were then transfected with speciﬁed doses
of vRNA using Lipofectamine 2000 as per manufacturer's protocol
(RNA (μg):Lipofectamine 2000 (μL) ratio of 1:2). For all vRNA
experiments, Poly I:C was included as assay control. Cells were
incubated for 3 h at 37 1C and 5% CO2, followed by sample
collection.
Recombinant HA stimulation
Puriﬁed recombinant HA protein was obtained from Sino
Biological Inc. (Beijing, China). Protein was expressed from DNA
sequences encoding the extracellular regions of A/Brisbane/59/
2007 (H1N1) or A/California/07/2009 (H1N1) HA. Stimulations of
NHBECs were performed in 6-well plates. 6-well plates were
seeded with 5.0104 cells/well and incubated overnight prior to
stimulation. Recombinant HA was diluted in sterile PBS and added
to cell supernatant (1 mL BEGM) at 1, 2, or 5 μg/mL. Cells were
incubated at 37 1C and 5% CO2 for 3 h until sample collection.
Cell viability
Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazoliumbromide (MTT; Sigma-Aldrich, St. Louis,
MO, USA) assay. Cells treated with 5 μM Cytochalasin B (Sigma-
Aldrich, St. Louis, MO, USA) were included as assay controls for all
experiments. At designated time points following infection, 20 μL
of freshly prepared 5 mg/mL MTT were added to infected and
mock infected cells in 96-well plates (ﬁnal MTT concentration:
500 μg/mL). Cells were incubated for 2 h at 37 1C and 5% CO2, after
which 25 μL 0.1 N hydrochloric acid/10% sodium dodecyl sulfate
was added to all wells. Cells were incubated and shook at room
temperature for 1 h. Absorbance at 570 nm and 670 nm was then
measured on plate reader, where OD570–OD670 corresponded to
cell viability. Cell viability of infected cells was expressed as
percentage of mock infected control cells. Wells containing media
only were similarly processed and measured as reference blanks.
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Host gene expression and viral load measurement by qRT-PCR
Total cellular RNA was collected and puriﬁed by RNEasy Mini
Kit (Qiagen, Hilden, Germany), as per manufacturer's instructions.
Puriﬁed RNA was then reverse transcribed using ImProm-II
Reverse Transcription System (Promega, Madison, WI, USA). qRT-
PCR was performed using the ABI-Prism 7900HT Sequence Detec-
tion Systems (Applied Biosystems, Foster City, CA, USA). Raw data
was collected with Applied Biosystems Sequence Detection Sys-
tems Version 2.3 software. Each reaction well contained 4 mL of
0.625 ng/uL cDNA, 0.5 mL each of forward and reverse primers
(ﬁnal concentration of 200 nM), and 5 mL SYBR Green Master Mix,
for a total reaction volume of 10 uL. Each sample was run in
quadruplicate. Host gene expression was normalized to the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeep-
ing gene, and quantiﬁed by the relative standard curve method.
Viral load was quantiﬁed by the absolute standard curve method,
normalized to GAPDH housekeeping. Primer sequences are listed
in Table S3.
Microarray gene expression analysis
Total cellular RNA from infected cells was collected and puriﬁed
by RNEasy Mini Kit (Qiagen, Hilden, Germany), as per manufacturer's
instructions. Puriﬁed RNAwas ampliﬁed with Illumina TotalPrep RNA
Ampliﬁcation Kit (Ambion, Austin, TX, USA) as per manufacturer's
instructions. cRNA (1.5 mg) was labeled and hybridized to HumanHT-
12 v4 Expression BeadChip (Illumina, San Diego, CA, USA) and
scanned on Illumina BeadStation 500GX. Raw data was collected
with Illumina GenomeStudio V2010.3 software. The data sets were
pre-processed with quantile normalization, variance stabilization,
and log2 transformation. Hierarchical clustering by Pearson's correla-
tion and heatmap representations were generated using MultiEx-
periment Viewer v4.6.2 (Dana–Farber Cancer Institute, Boston, MA,
USA). DAVID Bioinformatics Resource v6.7 (Huang da et al., 2008,
2009) was also used to perform functional classiﬁcation of differen-
tially expressed genes.
Microarray data accession number
Microarray expression data are MIAME compliant and are
available publicly in the MIAME-compliant Gene Expression Omni-
bus database (www.ncbi.nlm.nih.gov/geo/) under accession number
GSE48575.
Cytokine protein measurement
Supernatants were collected from infected cells, supplemented
with complete EDTA-free protease inhibitor cocktail (Roche Applied
Science, Laval, Canada) to prevent protein degradation, and stored at
20 1C prior to analysis. Inﬂammatory cytokine protein levels were
quantiﬁed by enzyme-linked immunosorbent assay (ELISA) as per
manufacturer's instructions. ELISA kits for CXCL1 and CXCL8 were
obtained from Aviscera Bioscience (Santa Clara, CA, USA).
Statistical methods
For all two group comparisons, the Student's t-test (α¼0.05)
was used to ascertain signiﬁcance. All Student's t-tests assumed
two-tailed distributions and two-sample unequal variances.
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